One giant commercial leap for cell and gene therapies

  • 2,000+cell & gene leaders
  • 30+expert speakers
  • 30+interactive sessions
  • 1month on demand content
  • 1proven virtual platform

Formulate, scale and standardize out-of-this-world launch strategies to bring your C&GTs to market fast and effectively.

While some developers are implementing lessons learned – and launching – their 2nd C&GTs to market, the majority are hoping the launch strategy for their 1st holds strong, as they navigate through a meteor shower of risky unknowns, firsts, new partnerships, and complexities the average pharma team has never experienced before.

To succeed commercially, pharma and biotech need to formulate a launch strategy that engages the right commercial resource early on, rewrites traditional payment models in partnership with payers, and provides an integrated delivery network that scales up seamlessly, end-to-end.

At Reuters Events' Cell & Gene Therapy USA 2021, you will receive key lessons learned from those who have already achieved lift off. C-suite, commercial strategy, manufacturing and supply, pricing and access experts will provide you with the tools to launch successfully and sustain and scale your cell and gene therapy delivery in to hyperdrive.

This event is free to attend for employees of pharma, biotech and payer organizations

A world-class speaker line up:

Suneet Varma - Headshot
Pfizer - Logo

Suneet Varma Global President, Rare Disease Pfizer

Stefan Hendriks - Headshot
Novartis - Logo

Stefan Hendriks Global Head, Cell & Gene Novartis

Kristen Hege - Headshot
BMS - Logo

Kristen Hege SVP Early Clinical Development, Hematology/Oncology & Cell Therapy BMS

Paul Granadillo - Headshot
Moderna - Logo

Paul Granadillo Senior Vice President, Global Supply Chain Moderna

Debbie Drane - Headshot
CSL Behring - Logo

Debbie Drane Senior Vice President, Global Commercial Development CSL Behring

Peter Marks - Headshot
FDA - Logo

Peter Marks Director, Center for Biologics Evaluation and Research (CBER) FDA

Key themes for 2021:

  • Start your engine: Effectively engage patients, physicians, payers, supply networks and internal superstars to ensure commercialization success.
  • Multi-stakeholder-proof your supply and delivery networks: Revolutionize manufacturing models for C&GT scale up, integrate data flow across complex delivery networks and match patient-preference with reduced turn-around times and POC treatment options.
  • Lift off in access and value: Partner with payers and policy makers in their language to create revolutionary payment models and secure a sustainable future for C&GTs.

What’s in it for you?

Commercial, Business & Strategy

  • Gain a high-level understanding of where trailblazers like Pfizer, BMS and Novartis failed and succeeded, implementing their lessons learned into your own launch strategy
  • Hear c-suite level views on the future of the cell and gene US market, put forward by scientific and commercial pharma experts
  • Deep dive into successful strategies for post-launch manufacturing scale up and delivery network integration which will reduce your turnaround time and lower costs
  • Learn how to build the most effective relationships with national and regional payers and policy makers, to ensure patient access and commercial sustainability

Manufacturing, Supply & Delivery

  • Define early industry best practices for C&GT manufacturing, as per key lessons learned from successful therapy launches
  • Understand how to incorporate manufacturing innovations in to your launch model, enabling shorter turnaround times, reduced cost of goods, and enhanced patient experience
  • Build robust and scalable delivery network, beyond the lab, that encourage multi-stakeholder collaboration, and enable seamless data transfer

Policy, Value & Access

  • Understand FDA approached to cell and gene therapy approvals – concerns and considerations – and learn how approval criteria are evolving as new therapies launch and new RWE and RWD is available
  • Explore payer mindsets, divisions and their differing considerations, based on their challenges, populations and indicators
  • Learn how to build meaningful partnerships with payers, engage them in early pricing conversations and develop payment strategies with payer needs at the forefront

Access the agenda and speaker line up, plus so much more

Why this conference is the must attend event

In-depth case studies

Practical, tangible advice and actions from your peers across the entire cell and gene value chain, that you can put into practise in your own company as you develop your commercialization strategy

A team learning experience

Now more than ever, we need to work together to effectively commercialize these incredible treatments for our customers and patients. Participate as a team of internal and external stakeholders to catch every drop of insight, make the most of networking and interactive sessions and unite to transform culture

Interactive at its core

We know you want more than just a series of online presentations – this is why live panels, real-time Q&A, virtual face-to-face workshops (pharma and biotech only) and online networking are all key experiences of Cell & Gene Therapy 2021 Virtual.

World-class online networking

Connect with like-minded attendees via a tried and tested, best-in-class platform, as well as interactive virtual workshops (pharma and biotech only) and social events to facilitate those chance encounters.

Benchmark against the leaders in cell & gene commercialization

We spend months uncovering the best examples of pharma and biotech going beyond business as usual in their attempts to commercialize effectively, with patient experience, speed of service and price at its core, so you can see how you compare against the leaders.

Align multiple stakeholders around the common cause

We get all the industry’s key stakeholders in the virtual room. Meet CROs, CDMOs, technology and solution providers, pharma and biotech with the collective aim of solving problems, speeding access and identifying patients in a constructive, collaborative manner

A snapshot of 2020’s senior decision makers:

Novartis's Logo
AveXis's Logo
BioMarin's Logo

Genentech's Logo

Vertex's Logo

Amgen's Logo

Spark Therapeutics's Logo
Alkermes's Logo

Sarepta Therapeutics's Logo

Janssen's Logo

Bayer's Logo
Astellas's Logo

Gilead Sciences's Logo
GSK's Logo
Roche's Logo

Cytiva's Logo

Biogen's Logo
UCB's Logo

EY's Logo
Pfizer's Logo

Takeda's Logo

Lonza's Logo
Bristol Myers Squibb's Logo
Audentes Therapeutics's Logo

Allergan's Logo

Representatives include:
  • Associate Director MSAT Raw Materials
  • Associate Director, IT for Commercialization
  • Business Partner, Cell Therapy IT Head
  • Business Technology Leader, Oncology & Cell Therapy
  • CAR-T Lead
  • Chief Commercial Officer
  • Chief Development Officer
  • Chief Medical Officer
  • Chief Operations Officer & Executive Vice President
  • Chief Technical Officer
  • Clinical Strategy Pharmacist
  • Commercial Director
  • Commercial Head
  • Commercial Payer Lead
  • Director - Global Commercial Gene Therapy
  • Director Technology Services - Supply Chain Integrations
  • Director, Business Development
  • Director, Channel Access and Patient Strategy
  • Director, global disease strategy hematology
  • Director, Market Access
  • Director, R&ED IT, Business Partner - Cell Therapy & Early Clinical Development
  • Director, Science and Regulatory Policy
  • Executive Director
  • Executive Medical Director, US Medical Affairs
  • Global Executive Medical Director
  • Global Head Innovation Communications
  • Global Lead Public Affairs - Cell & Gene Therapy
  • Global Product Communications
  • Global Program Manager
  • Global Solutions Marketing Leader - Cell Therapy
  • Head of Clinical Operations
  • Head of Commercial Supply Chain | Cell & Gene Therapy
  • Head of Emerging Technologies
  • Head of EU operations
  • Head of Regulatory Affairs, Personalized Medicine
  • Head, Commercial Strategy and Execution US
  • Innovation Platform Leader
  • Lead Business Partner
  • Manager Global Supply Chain
  • Manager Pricing and Access
  • Manager Pricing/Contracting CGT
  • Medical director
  • Patient Access Sr. Associate
  • President
  • President/Founder
  • Pricing Oncology/Cell Gene Therapy
  • Principal
  • Senior Consultant, Specialty Pharmacy Medical Benefit Solutions
  • Senior Director, Market Access
  • Senior Manager, Corporate Affairs
  • Senior Manager, Global Evidence & Outcomes
  • Solid Tumors Franchise Head
  • Sr Dir corporate strategy and commercialization
  • Sr Director Trade & Distribution
  • Sr Director, Global Commercial GTx Lead
  • Sr Manager - FP&A
  • Sr. Director Cell and Gene Therapies Companion Diagnostics
  • Sr. Global Program Manager Data Management
  • Sr.Director, Cell therapy late stage CMC strategy & BD
  • Supply Chain Director
  • SVP Global Business Development
  • SVP, Americas
  • SVP, Commercial Strategy & Capabilities
  • Therapeutic Area Manager
  • US Strategy Leader, Reimbursement and Patient Engagement
  • Vice President, Channel & Commercial Strategy
  • Vice President, Government Affairs and Advocacy
  • Vice President, Market Access
  • Vice President, Translational Research
  • VP & TA Co-Lead
  • VP Diagnostic Strategy
  • VP Patient Access
  • VP, Global Supply Chain
  • VP, Primary Focus Lead

Delivering an exceptional virtual event experience including:

technology/large/wifi Created with Sketch. Watch Live Watch presentations, fireside chats and panel discussions from top industry thought-leaders all day, every day!

user-interface/large/comment-add Created with Sketch. Discuss Comment and question in real time. Spark conversations with your fellow attendees and build those relationships with instant chat, video calls and discussion groups.

files-folders/large/question Created with Sketch. Question Get in-depth answers in real-time with our live Q&A sessions with every presentation and panel speaker!

technology/large/player-19 Created with Sketch. On-Demand Missed a session? Catch-up in your own time through our on-demand service for 2 weeks. Imagine Netflix but the best of pharma thought leadership.

shopping/large/mobile-touch Created with Sketch. Personalize Create your own conference agenda and export it to your calendar, so you don’t miss business critical sessions.

business-finance/large/connect Created with Sketch. Connect Meet and build relationships with fellow attendees who share the same challenges and interests as you with our Intelligent Networking platform

Register now - Join 2,000+ pharma leaders!

Continue to build your network in the new world of virtual and hybrid interaction

We know that a virtual event doesn’t always deliver on the “chance encounters” that can be so valuable from a physical conference, but with the networking and messaging suite at Cell & Gene Therapy USA, you’ll be guaranteed a service that allows you to connect with and meet attendees who are relevant to your business, interests and challenges.

  • Connect with the right peers:  With 1,000+ attendees, it can be hard to know who to connect with on the virtual platform but with Intelligent Networking, you’ll be recommended peers to connect with, based on the same interests and challenges you face.
  • Build relationships: With instant chat, video calls and discussion groups all within the Cell & Gene Therapy USA virtual platform, you can build relationships with speakers, attendees and sponsors,
  • Dig deep into the topics that matter to you: With private and public discussion groups on specific topic areas, you’ll be able to connect with attendees that care about the things you do, and discuss solutions and future opportunities.

How it works

shopping/large/customer-support Created with Sketch.

Instant chat

technology/large/laptop-1 Created with Sketch.

Video calls

user-interface/large/comment-add Created with Sketch.

Roundtable discussions

user-interface/large/search-2 Created with Sketch.

Searchable attendee list

user-interface/large/event-confirm Created with Sketch.

Schedule meetings

Created by Fruitbowl Media Ltd.

Private group chats

Access the agenda and speaker line up, plus so much more

Exceptional online networking opportunities (for pharma, biotech, and sponsors)

You won’t find an online cell and gene commercialization networking experience elsewhere. Reuters Events Pharma Cell & Gene Therapy USA 2021 is the only place to connect with commercialization leaders, patient experience experts, pricing and policy advisors, engagement and education front-runners. Here’s how:

  • Connect 1-on-1 with fellow attendees: Over several weeks, you’ll have access to our online messaging platform, allowing you to connect with like-minded pharma leaders and set up a virtual coffee or formal meeting in your own time.
  • Interactivity: With 15+ interactive sessions including virtual workshops, live Q&As and panels, make your voice heard as a thought leader via the speaker question and messaging functions

Best-in-class virtual conference experience

Reuters Events has an NPS Score of 83.

* Company NPS scores acquired from

World class!

A special experience by any measure!


Register now - Join 2,000+ pharma leaders!

Reuters Events Pharma: Industry leaders in virtual events

This is not our first rodeo. April this year we turned two of the industry’s largest events, Reuters Events Pharma (formerly eyeforpharma) Philadelphia and Barcelona, into virtual events in the space of a month. With over 30,000 total attendees, here’s what people thought…

Reuters Events has once again proven why they are the leaders in this space

Extremely interesting and provided great insights into the best practices and ways of moving forward in the future.

An extraordinary, pioneering job!

The content was superb and well done.

Excellent sessions providing great insights into the future of pharma.

Congratulations on the eyeforpharma virtual work! Very interesting talks and extremely well organised.

I’m grateful to Reuters Events for making it possible to connect.

This is a great forum and it's working so nicely. Deep and thoughtful exploration.

Congratulations and a huge thank you for this virtual event!

Excellent facilitation and fascinating discussions

Congratulations on the virtual eyeforpharma event! It was a great experience! Thank you for all the insights.

I couldn’t help but feel that I was witnessing the roots of the future being sown today.

Another successful event in Pharma at such challenging times

Holy Sh*t – so impressed!

Wonderful platform. Very valuable.

It was a sheer privilege and an honour to participate.

Thank you for arranging such an event; it is really inspiring and also motivating during this difficult period.

Thank you so much for providing this program virtually… I have learned so much.

It was a memorable experience for the industry.

Thanks for hosting this and having it free so patient advocates could really attend!

This was conference was very well done! Thank You.

Brilliantly DONE!

Its an amazing way for networking.

This virtual conference turned out amazingly done! Good job!

The conference hits on everything I am passionate about.

Many thanks for educating all of us in this difficult time!

Access the agenda and speaker line up, plus so much more

Here to help

Get in touch with the Reuters Events team